Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska.
Section of Epidemiology, Division of Public Health, Alaska Department of Health and Social Services, Anchorage, Atlanta, Georgia.
Clin Infect Dis. 2018 Mar 19;66(7):1068-1074. doi: 10.1093/cid/cix921.
In 2016, we detected an outbreak of group A Streptococcus (GAS) invasive infections among the estimated 1000 persons experiencing homelessness (PEH) in Anchorage, Alaska. We characterized the outbreak and implemented a mass antibiotic intervention at homeless service facilities.
We identified cases through the Alaska GAS laboratory-based surveillance system. We conducted emm typing, antimicrobial susceptibility testing, and whole-genome sequencing on all invasive isolates and compared medical record data of patients infected with emm26.3 and other emm types. In February 2017, we offered PEH at 6 facilities in Anchorage a single dose of 1 g of azithromycin. We collected oropharyngeal and nonintact skin swabs on a subset of participants concurrent with the intervention and 4 weeks afterward.
From July 2016 through April 2017, we detected 42 invasive emm26.3 cases in Anchorage, 35 of which were in PEH. The emm26.3 isolates differed on average by only 2 single-nucleotide polymorphisms. Compared to other emm types, infection with emm26.3 was associated with cellulitis (odds ratio [OR], 2.5; P = .04) and necrotizing fasciitis (OR, 4.4; P = .02). We dispensed antibiotics to 391 PEH. Colonization with emm26.3 decreased from 4% of 277 at baseline to 1% of 287 at follow-up (P = .05). Invasive GAS incidence decreased from 1.5 cases per 1000 PEH/week in the 6 weeks prior to the intervention to 0.2 cases per 1000 PEH/week in the 6 weeks after (P = .01).
In an invasive GAS outbreak in PEH in Anchorage, mass antibiotic administration was temporally associated with reduced invasive disease cases and colonization prevalence.
2016 年,我们在阿拉斯加安克雷奇的大约 1000 名无家可归者(PEH)中检测到 A 组链球菌(GAS)侵袭性感染的爆发。我们对疫情进行了描述,并在无家可归者服务机构实施了大规模抗生素干预措施。
我们通过阿拉斯加 GAS 基于实验室的监测系统确定病例。我们对所有侵袭性分离株进行 emm 分型、抗菌药物敏感性测试和全基因组测序,并比较了感染 emm26.3 和其他 emm 型的患者的病历数据。2017 年 2 月,我们向安克雷奇的 6 家机构的 PEH 提供了 1 克阿奇霉素的单剂量。我们在干预的同时和之后的 4 周内,从一组参与者中采集了咽和非完整皮肤拭子。
从 2016 年 7 月至 2017 年 4 月,我们在安克雷奇检测到 42 例侵袭性 emm26.3 病例,其中 35 例发生在 PEH 中。emm26.3 分离株平均仅相差 2 个单核苷酸多态性。与其他 emm 型相比,感染 emm26.3 与蜂窝织炎(比值比 [OR],2.5;P =.04)和坏死性筋膜炎(OR,4.4;P =.02)有关。我们向 391 名 PEH 发放了抗生素。emm26.3 的定植率从基线时的 277 人中的 4%降至随访时的 287 人中的 1%(P =.05)。侵袭性 GAS 的发病率从干预前 6 周的每 1000 名 PEH/周 1.5 例降至干预后 6 周的每 1000 名 PEH/周 0.2 例(P =.01)。
在安克雷奇无家可归者中侵袭性 GAS 爆发期间,大规模抗生素治疗与侵袭性疾病病例和定植率的降低有关。